During the last decade, the possibility that 'mild' uncoupling could be protective against oxidative damage by diminishing ROS (reactive oxygen species) production has attracted much interest. In the present paper, we briefly examine the evidence for this possibility. It is only ROS production from succinate under reverse electron-flow conditions that is sensitive to membrane potential fluctuations, and so only this type of ROS production could be affected; however, the conditions under which succinate-supported ROS production is observed include succinate concentrations that are supraphysiological. Any decrease in membrane potential, even 'mild uncoupling', must necessarily lead to large increases in respiration, i.e. it must be markedly thermogenic. Mitochondria within cells are normally ATP-producing and thus already have a diminished membrane potential, and treatment of cells, organs or animals with small amounts of artificial uncoupler does not seem to have beneficial effects that are explainable via reduced ROS production. Although it has been suggested that members of the uncoupling protein family (UCP1, UCP2 and UCP3) may mediate a mild uncoupling, present evidence does not unequivocally support such an effect, e.g. the absence of the truly uncoupling protein UCP1 is not associated with increased oxidative damage. Thus present evidence does not support mild uncoupling as a physiologically relevant alleviator of oxidative damage.
Concept of ('mild') uncoupling as a protection against oxidative damage
The underlying premises in all discussions concerning the concept of 'mild uncoupling' as protection against oxidative damage [1, 2] are that mitochondria, within cells, will reach high membrane potentials and that this will induce ROS (reactive oxygen species) production and thus oxidative damage, and that therefore a 'mild uncoupling' (e.g. through activation of uncoupling proteins by ROS or ROS products as a negative feedback, preventing further superoxide production [3] ) would decrease oxidative damage. However, each of these premises is debatable. In the present paper, we discuss several of these issues, namely the premise that the membrane potential controls the rate of ROS production; the premise that 'mild' uncoupling may reduce superoxide production without significantly increasing thermogenesis and thus be beneficial; the premise that mitochondria within cells reach high membrane potential; and the premise that UCP (uncoupling protein) 1/2/3 are capable of ('mild') uncoupling and thus are protective against oxidative damage.
Control of ROS production by protonmotive force is an exclusive feature of succinate
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and that the addition of an uncoupler totally inhibited this ROS production. This experiment has been seminal for the concept of mitochondrial ROS production and its regulation by the membrane potential, leading to the now apparently accepted general concept that membrane potential controls the rate of ROS production in vivo. The problem is that this experiment, while being well substantiated for succinate over the years, is not generally relevant for all ROS production by mitochondria. Rather, as detailed below, it is succinate that is the exception.
Indeed, isolated mitochondria respiring on succinate (in the absence of rotenone) have the highest known levels of endogenous superoxide production [5] [6] [7] . As rotenone inhibits this succinate-supported ROS production, most ROS are derived from reverse electron flow from succinate dehydrogenase to Complex I. This mode of succinatesupported ROS generation is very sensitive to depolarization of membrane potential. Not only can uncouplers inhibit it, but even the depolarization associated with ATP generation is sufficient to inhibit this ROS production [5, 6, 8] .
in kidney, heart, liver, muscle or brown adipose tissue [9] [10] [11] . This may be because much of the ROS is derived from the glycerol 3-phosphate dehydrogenase itself [9, 12] .
Similarly, in mitochondria from various tissues, oxidation of fatty acids, despite being a powerful source of FADH 2 , does not lead to reverse-electron-flow-associated high ROS generation [11, 13] . It is not fully understood as to why this would exclude the membrane-potential-sensitive reversed electron flow that should generate ROS here as well, but it has been suggested that this electron flow is dependent on the formation of supercomplexes that are only formed with succinate [13] . Thus, among Complex-II-linked substrates, only succinate displays membrane potential sensitivity.
Complex-I-linked substrates do not display membrane-potential ROS production Mitochondria respiring on Complex-I-linked substrates (2-oxoglutarate or pyruvate or glutamate, all in the presence of malate), produce very little ROS unless Complex I itself is inhibited with rotenone [5] [6] [7] . This mode of ROS production is insensitive to changes in protonmotive force [5] . Accordingly, FCCP (carbonyl cyanide ptrifluoromethoxyphenylhydrazone) addition has no effect on ROS production supported by Complex I substrates in brain, heart, liver, kidney or muscle mitochondria [11] .
Superoxide production from forward electron transport in the presence of substrates that reduce NAD + is primarily from fully reduced flavin within complex I (reviewed in [14, 15] ). This site is thus different from the site of semireduced coenzyme Q at the coenzyme Q-binding site of Complex I, which is the site of superoxide production under reverse electron-transport conditions. An inhibition of the respiratory chain by damage, mutation, ischaemia, loss of cytochrome c or by the build-up of NADH due to low ATP demand and a consequently low respiration rate will increase the NADH/NAD + ratio and lead to high superoxide production from the flavin site of Complex I (reviewed in [15] ). Thus a high membrane potential as such is not among the factors that induce ROS production with Complex-I-linked substrates.
Thus only succinate-supported ROS production under conditions where reverse electron flow is promoted is sensitive to membrane potential alterations.
Is succinate a physiologically relevant substrate?
Although it is well substantiated experimentally that succinate-supported ROS production is membranepotential-sensitive and thus could be reduced by a reduced membrane potential, it may be debated whether the conditions routinely used to demonstrate this reflect conditions occurring in vivo.
For in vitro studies of isolated mitochondria, 3-10 mM succinate is normally used experimentally [6] . Zoccarato et al. [16, 17] tried to identify the lowest concentration of succinate capable of inducing ROS production and found that a measurable effect appeared only at succinate concentrations higher than approximately 0.5 mM. As succinate is really only a citric acid cycle intermediate in metabolism, the issue is whether such succinate concentrations are ever reached in vivo.
In reality, the cellular physiological concentration of succinate is negligible (below the threshold for reliable detection by proton magnetic resonance spectroscopy). Succinate only becomes detectable in metabolic disorders (Complex II deficiencies) or as an intermediate product of bacterial metabolism in certain infections [18, 19] . In a few studies where succinate was detected in vivo under normal conditions, extremely low succinate concentrations were found. In the working heart, succinate reached a concentration of 0.3 μmol/g of dry weight, whereas glutamate reached a concentration approximately 100-fold higher (20 μmol/g of dry weight) [20] . In kidney, a highest concentration of 10 μM has been reported [21] .
Thus it is doubtful whether succinate levels necessary to induce ROS production are ever reached in vivo. Therefore only physiological substrates (in reality pyruvate, glutamate and fatty acids) should be considered when the concept of a protective effect of 'mild' uncoupling is discussed, and ROS production from these substrates is not membrane-potentialsensitive.
'Mild uncoupling': a non-Mitchellian concept?
Although not formally defined, the term 'mild uncoupling' has become extremely popular in ROS-related literature over the last decade. It would seem that the term is used to indicate a decrease in membrane potential of some tens of millivolts (occurring through other means than ATP production), in contrast with the practically full disappearance of membrane potential observed after standard application of artificial uncouplers.
Indeed, the premise that 'mild' uncoupling is sufficient to significantly decrease superoxide production is substantiated by observations that, e.g., a 10 mV depolarization may lead to a marked decrease in the rate of ROS production from succinate under experimental conditions [1, 2] .
However, it seems that occasionally a concept is implied (or even illustrated) where there should be a kind of 'grace space' concerning the membrane potential, so that a small decrease in membrane potential would not result in an increase in respiration (but only result in a decrease in ROS production). Unfortunately, this concept is not correct. Thus, although 10 mV may not seem much, a depolarization of this magnitude must lead to substantial increases in the rate of oxygen consumption, both based on the established Mitchellian control of respiratory-chain activity and as confirmed by parallel measurements of respiration and ROS production. Indeed, as illustrated in Figure 1 , it is clear even from one of the first studies implying 'mild uncoupling' as a means to decrease ROS production that a membrane potential decrease that diminishes ROS production by 90 % is necessarily associated with a 200 % increase in basal respiration, i.e. ('mild uncoupling') diminishes ROS production but simultaneously increases respiration markedly, resulting in high thermogenesis Based on data in [8] , obtained by the addition of small amounts of uncoupler to heart mitochondria.
nearly the same increase as that observed during high levels of ATP synthesis. Thus induction of mild uncoupling must necessarily be highly thermogenic. In another formulation, mild uncoupling is such a lowering of the membrane potential that still allows for ATP synthesis (i.e. an addition of ADP still leads to a stimulation of respiration). This formulation does not contradict Mitchellian views, but evidently the thermogenic effect of the mild uncoupling cannot be escaped.
The issue of 'mild uncoupling' as a protectant against oxidative damage
Even given the limitations that only succinate-supported ROS production (and only with experimental succinate concentrations) can be diminished by a (small) decrease in membrane potential, it must be questioned whether physiological conditions ever occur where this would be relevant. Basically this must mean that mitochondria within cells should often be in State-4 conditions, i.e. not producing ATP and therefore having a high membrane potential.
However, normally, when metabolism is investigated in isolated cell systems of any kind, the rate of oxygen consumption is clearly inhibitable by oligomycin, indicating ongoing ATP synthesis (e.g. [22] ) and thus a membrane potential that is already lowered. Thus it is unlikely that mitochondria ever 'need' a mechanism for partial uncoupling because they will always physiologically be in a state with a non-maximum membrane potential (as is always the case when ATP is being synthesized).
This implication is supported by evidence concerning the effect of limited artificial uncoupling [with FCCP or DNP (2,4-dinitrophenyl)] on ROS production and cell survival in cellular systems. In contrast with the predicted outcome of the 'mild uncoupling' theory, such treatment actually increases (instead of decreases) cellular ROS production, causing apoptosis or senescence [23, 24] . Small concentrations (far from toxic but able to induce decrease of membrane potential) of uncoupler are not protective against ROS release in neuronal cells [25, 26] . Only in one cellular study was FCCP shown to decrease ROS production [27] . Thus the present results at the cellular level do not provide strong support for the idea that mild uncoupling should be a preferred avenue for antioxidative damage treatment at the cellular level.
Possible protective effects of uncouplers have been also studied at higher levels of biological organization. FCCP was applied during heart perfusion; only one specific dose could improve post-ischaemic functional recovery of heart via a ROS-dependent pathway [28] . There was no explanation in this study as to why only one single dose among several tested was efficient [28] . Also, in a similar isolated heart system, uncouplers caused profound QT shortening and triggered ventricular fibrillation in 100 % of hearts [29] , making the idea of mild uncoupling as a treatment alleviating postischaemic damage less promising. Ischaemic preconditioning apparently leads to decreased proton leak and thus increased membrane potential, but also to decreased ROS production, i.e. the opposite of what the mild uncoupling hypothesis would imply [30] .
At the intact animal level, only one specific dose of FCCP (among four tested) was found to be neuroprotective after traumatic brain injury [31] . ROS production and oxidative damage were not examined in that study, and a rational choice of dose was not provided [31] . The studies in [32] demonstrate that weak chronic uncoupling of mice may be beneficial for longevity, including being associated with less oxidative damage. However, the uncoupler-treated mice were, for example, also less obese, and as obesity in itself is also associated with increased oxidative stress, the reduced oxidative damage observed may not necessarily be a primary effect of the diminished mitochondrial membrane potential.
Thus currently there is no entirely convincing evidence that 'mild uncoupling' has beneficial effects mediated via decreased ROS production.
UCP1, UCP2 and UCP3 and mild uncoupling
Even though there is little to indicate that uncoupling is generally beneficial as protection against oxidative damage at the cellular, organ or intact animal level, there is reason to discuss the idea that mild uncoupling could be achieved through the action of UCP1, UCP2 or UCP3.
We have previously critically examined the evidence that UCP2/UCP3 become true uncoupling proteins when stimulated by ROS or 4-hydroxynonenal, and thus become capable of diminishing oxidative damage by a feedback mechanism activating 'mild' uncoupling [33] . Now, 5 years later, we can summarize that the evidence for such a physiologically significant role is still circumstantial and has become even more disputed [7, [34] [35] [36] [37] . In view of the fact that UCP3 and particularly UCP2, compared with UCP1, are The left-hand part of this Figure represents actual data obtained with isolated brown-fat mitochondria from a wild-type mouse, examined as detailed in [47] . The uncoupling capacity of UCP1 (corresponding to 120 nmol of O 2 /min per mg of mitochondrial protein) is rate-limiting for the proton leak observed, because the addition of FCCP leads to an even higher rate of oxygen consumption (results not shown), and because alterations in UCP1 amount results in a proportional increase in proton leak [42] . The levels of UCP2 protein observed in different tissues are much lower than the levels of UCP1 in brown adipose tissue (BAT); the highest level is found in spleen and is ∼160-fold lower [48] . Provided that the proton-conducting capacity of activated UCP2 is equally high as that of UCP1, the expected 'uncoupling' observed in the best tissue would be of the size of the point encircled, that is, unobservable. present in very low amounts in the mitochondrial membrane (Figure 2) , it is currently unclear as to how they could catalyse a sufficiently high proton leak to allow for the degree of uncoupling needed to lower the mitochondrial membrane potential measurably, even if they were truly UCPs.
UCP1 is the only verified uncoupling protein [38] ; it does lead to diminished membrane potential when active, and it therefore undoubtedly has the potential to regulate membrane-potential-sensitive ROS production. Despite a clear difference in membrane potential levels, brown fat mitochondria with/without UCP1 produce equal amounts of superoxide as determined by the dihydroethidium method [39, 40] . These experiments were conducted with glycerol 3-phosphate as the substrate and in the presence of rotenone, and reverse electron flow was thus inhibited. The absence of effect of uncoupling on ROS was therefore as expected, as discussed above. When similar experiments are performed with succinate without rotenone, the expected results are reported: succinate-supported, but not glycerol 3-phosphatesupported or pyruvate-supported, ROS production is higher in mitochondria without UCP1 or in mitochondria where UCP1 activity is inhibited [41] .
Thus the non-uncoupling 'uncoupling proteins' UCP2 and UCP3 cannot mediate 'mild uncoupling', and the truly uncoupling 'uncoupling protein' UCP1 can only influence succinate-supported ROS production, as would be expected from data on uncoupling effects in other mitochondrial types than brown-fat mitochondria.
The brown adipose tissue system therefore provides an opportunity to examine whether the presence of a system for regulated uncoupling is important for protection against oxidative damage. However, a comparison between oxidative damage in brown-fat mitochondria from mice possessing UCP1 or not revealed no differences due to the presence or absence of UCP1 [39] , and cold acclimatization or highfat diet, both of which increase the amount of UCP1 [42, 43] , also increase the rate of H 2 O 2 formation and oxidative stress [43] [44] [45] [46] . Thus there is no indication that UCP1-mediated uncoupling diminishes oxidative damage.
Conclusions
The possibility that 'mild uncoupling' may alleviate oxidative damage has attracted much interest. However, an analysis of the data generated in relation to this hypothesis implies that the physiological relevance of this hypothesis is debatable. Thus only succinate-derived ROS production is induced by a high membrane potential, and the succinate concentrations needed to observe this ROS production are supraphysiological. Mild uncoupling must always be associated with a highly increased thermogenesis. It is unlikely that mitochondria within cells ever reach State-4 conditions with high membrane potential. The evidence that any member of the UCP family may mediate mild uncoupling when stimulated with ROS products is becoming less convincing as back-crossed animals are analysed. Thus it is difficult to see that 'mild uncoupling' has physiological or therapeutic significance.
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